SKI Market

Indian Indices

Nifty

26,053.90 117.70
(0.45%)

Sensex

84,724.30 -272.83
( -0.32%)

Bank Nifty

58,385.25 171.15
( 0.29%)

Nifty IT

36,090.10 229.70
( 0.64%)

Global Indices

Nasdaq

47,640.49 -86.88
(-0.18%)

Dow Jones

6,909.03 -2.86
(-0.04%)

Hang Seng

51,290.81 1,071.63
(2.13%)

Nikkei 225

9,748.97 52.23
(0.54%)

Forex

USD-INR

88.25 0.13
(0.15%)

EUR-INR

102.86 0.33
(0.32%)

GBP-INR

117.45 -0.02
(-0.02%)

JPY-INR

0.58 0.00
(0.68%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Novartis India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500672

INE234A01025

313.912669

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NOVARTIND

20.22

2155.75

EPS(TTM)

Face Value()

Div & Yield %

43.17

2.86

Back

Novartis India standalone net profit rises 18.67% in the September 2025 quarter

Oct 28,2025

Net profit of Novartis India rose 18.67% to Rs 24.22 crore in the quarter ended September 2025 as against Rs 20.41 crore during the previous quarter ended September 2024. Sales rose 3.71% to Rs 90.33 crore in the quarter ended September 2025 as against Rs 87.10 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	90.33	87.10	4
OPM %	26.44	20.62	-
PBDT	33.17	28.14	18
PBT	32.65	27.56	18
NP	24.22	20.41	19

26,053.90 117.70 (0.45%)

84,724.30 -272.83 ( -0.32%)

58,385.25 171.15 ( 0.29%)

36,090.10 229.70 ( 0.64%)

47,640.49 -86.88 (-0.18%)

6,909.03 -2.86 (-0.04%)

51,290.81 1,071.63 (2.13%)

9,748.97 52.23 (0.54%)

88.25 0.13 (0.15%)

102.86 0.33 (0.32%)

117.45 -0.02 (-0.02%)

0.58 0.00 (0.68%)